| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,564 | 21,266 | 12,294 | 19,693 | | Cost of Revenue | 14,023 | 19,577 | 10,841 | 14,655 | | | Gross Profit | 2,541 | 1,689 | 1,453 | 5,038 | | | Operating Expenses | | Research Development | 220 | 251 | 311 | 321 | | Selling General and Administrative | 4,320 | 4,904 | 4,045 | 5,595 | | Non Recurring |
-
| (200) | (1,535) | (6,761) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,999) | (3,266) | (1,368) | 5,883 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,561 | (70) | 209 | (50) | | Earnings Before Interest And Taxes | (2,390) | (4,079) | (1,439) | 5,435 | | Interest Expense | (134) | 76 | 58 | 43 | | Income Before Tax | (2,256) | (4,155) | (1,497) | 5,392 | | Income Tax Expense | 23 | 14 | 27 | 270 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,279) | (4,169) | (1,524) | 5,122 | | | Non-recurring Events | | Discontinued Operations | (1,248) | (391) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,527) | (4,560) | (1,524) | 5,122 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,527) | ($4,560) | ($1,524) | $5,122 |
|
0.26% Nasdaq 
0.52 (10.86%) 
Income Statement
